Tradestie Institutional Equity Comparison Engine

CNEY vs BON โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

BON Overall Edge

BON Captures Institutional Edge (3โ€“0 Pillars ยท 8โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Bon Natural Life Limited Class A Ordinary Shares (BON) driven by superior Valuation, Growth & Margin, Momentum & Technical. Fundamentally, CNEY trades at N/M Forward P/E with -138.5% operating margin (+8.2% YoY revenue) versus BON at 2.4x Forward P/E and -45.5% operating margin (+1.9% YoY). In options structure, CNEY sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against BON sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner BON
CNEY N/M vs BON 2.4x Fwd P/E
Growth & Margin Winner BON
Op Margin -138.5% vs -45.5% ยท YoY +8.2% vs +1.9%
Momentum & Technical Winner BON
1Y -73.1% vs -43.4% ยท 52W Pos 5% vs 12%
Options & Structure Winner Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
CNEY NASDAQ
CN Energy Group Inc. Class A Ordinary Shares
Industrial Organic Chemicals
$0.43
-9.9% 1D
Market Cap $2.6M
1M Return +9.16%
1Y Return -73.14%
Forward P/E N/M
Unified AI Score
35.1 / 100 SELL
Tech 15.0 Fund 45.0 Flow 50.0 Mom 50.0
BON NASDAQ
Bon Natural Life Limited Class A Ordinary Shares
Medicinal Chemicals & Botanical Products
$1.07
-1.83% 1D
Market Cap $9.0M
1M Return -4.35%
1Y Return -43.39%
Forward P/E 2.4x
Unified AI Score
52.3 / 100 HOLD
Tech 37.0 Fund 49.0 Flow 50.0 Mom 73.6

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CNEY -73.14% BON -43.39% Spread: +29.75 pp (BON Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CNEY TTM Op. Margin: -138.5% BON TTM Op. Margin: -45.5%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CNEY vs BON. Trailing 12-month operating profitability (CNEY -138.5% vs BON -45.5%) and valuation multiples (CNEY N/M vs BON 2.4x Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CNEY (1) vs BON (8)
Institutional Metric CNEY BON Criterion Row Winner
Market Capitalization Scale $2.6M $9.0M Larger Scale Tie
Trailing P/E Ratio Valuation N/M 2.4x Lower Multiple BON
Forward P/E Ratio Valuation N/M 2.4x Lower Multiple BON
Revenue Growth (YoY) Growth +8.2% +1.9% Higher Growth CNEY
Operating Margin (TTM) Profitability -138.5% -45.5% Higher Margin BON
Net Profit Margin Profitability -183.1% -60.4% Higher Margin BON
Return on Equity (ROE) Capital Efficiency -84.3% -21.8% Higher ROE BON
52-Week Range Position Momentum 5% ($0โ€“$3) 12% ($1โ€“$2) Stronger Trend BON
Beta / 30D Volatility Risk Regime 0.67ฮฒ ยท 104% Vol -0.08ฮฒ ยท 30% Vol Lower Realized Risk BON
Unified Institutional Score Composite Signal 35.1 / 100 (SELL) 52.3 / 100 (HOLD) Higher Composite BON

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CNEY vs BON Buy Guide
CNEY UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live CNEY Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
BON UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live BON Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CNEY nor BON registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.